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Abstract
Background: Campylobacter is the leading cause of foodborne diarrhoeal illness in humans and is mostly acquired
from consumption or handling of contaminated poultry meat. In the absence of effective licensed vaccines and
inhibitors, selection for chickens with increased resistance to Campylobacter could potentially reduce its subsequent
entry into the food chain. Campylobacter intestinal colonisation levels are influenced by the host genetics of the
chicken. In the present study, two chicken populations were used to investigate the genetic architecture of avian
resistance to colonisation: (i) a back-cross of two White Leghorn derived inbred lines [(61 x N) x N] known to differ
in resistance to Campylobacter colonisation and (ii) a 9th generation advanced intercross (61 x N) line.
Results: The level of colonisation with Campylobacter jejuni following experimental infection was found to be a
quantitative trait. A back-cross experiment using 1,243 fully informative single nucleotide polymorphism (SNP)
markers revealed quantitative trait loci (QTL) on chromosomes 7, 11 and 14. In the advanced intercross line study,
the location of the QTL on chromosome 14 was confirmed and refined and two new QTLs were identified located
on chromosomes 4 and 16. Pathway and re-sequencing data analysis of the genes located in the QTL candidate
regions identified potential pathways, networks and candidate resistance genes. Finally, gene expression analyses
were performed for some of the candidate resistance genes to support the results.
Conclusion: Campylobacter resistance in chickens is a complex trait, possibly involving the Major Histocompatibility
Complex, innate and adaptive immune responses, cadherins and other factors. Two of the QTLs for Campylobacter
resistance are co-located with Salmonella resistance loci, indicating that it may be possible to breed simultaneously
for enhanced resistance to both zoonoses.
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Quantitative trait
Background
Campylobacter is the leading cause of foodborne acute
enteritis in humans in the developed world. The
condition is usually self-limiting and symptoms last for
5–7 days, but in some cases the infection may be com-
plicated by severe sequelae [1–3]. Epidemiology un-
equivocally implicates poultry as a key reservoir of
human infection and up to 80 % of human cases may be
attributable to the avian reservoir as a whole [4]. A re-
cent year-long survey found Campylobacter in 73 % of
chicken on retail sale in the United Kingdom [5]. There
were 66,575 laboratory-confirmed human infections
(mostly due to Campylobacter jejuni) and an estimated
total of 685,000 cases in the UK in 2013 [6]. The num-
ber of Campylobacter jejuni (C. jejuni) in the caeca of
chickens can exceed 108 colony-forming units (CFU)/g
and escape of gut contents and cross-contamination at
slaughter is difficult to avoid. Quantitative risk assess-
ments predict that even a relatively modest 2 log10
reduction in the number of Campylobacter in broiler
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carcasses could reduce the incidence of human disease
due to infected chicken by up to 30-fold [7]. Therefore,
a pressing need exists for strategies to reduce the entry
of Campylobacter into the food chain. In the absence of
effective licensed vaccines and inhibitors, selection for
chickens with increased resistance to Campylobacter in-
testinal colonisation provides a sustainable complimentary
control strategy.
There is a widely–held perception that Campylobacter
is an inert commensal of birds. However, experimental
infection of chickens with Campylobacter induces a
rapid influx of heterophils (the avian functional equiva-
lent of the mammalian neutrophil) into the gut and the
production of pro-inflammatory cytokines and chemo-
kines in the intestinal epithelium [8]. Maternal C. jejuni-
specific antibodies protect chicks against experimental
infection [9, 10] and are associated with the delayed in-
cursion of Campylobacter into flocks [10, 11]. In some
breeds of chicken, C. jejuni elicits prolonged inflamma-
tory responses, damage to the intestinal mucosa, diar-
rhoea and failure to thrive [12, 13]. Conversely, both
innate and acquired immune responses have been asso-
ciated with differential resistance to Campylobacter in-
testinal colonisation [14–16].
The innate immune response to pathogen challenge
and disease resistance varies between birds in inbred
lines and outbred populations [12, 17–21]. The ability of
C. jejuni to colonise the intestines differs amongst White
Leghorn chicken inbred lines, with lines 61 and N being
at the extremes of phenotype [22]. An initial reciprocal
backcross experiment between inbred lines 61 and N re-
vealed that the difference in bacterial numbers was herit-
able [22], but the host genetic mechanism of resistance
to Campylobacter colonisation is not known. One pub-
lished genome-wide association study (GWAS) of C.
jejuni intestinal colonisation status (phenotypes analysed
as a binary trait) in a novel dual-purpose chicken breed
revealed one candidate locus on chromosome 11 near
the CDH13 gene [23]. There are also several studies of
caecal gene expression analysis in chicken lines with dif-
ferent susceptibility to Campylobacter colonisation
showing variation in transcription of genes influencing
immune response [14, 15, 24].
The aim of the present study was to extend a previous
investigation of inbred lines of chickens to determine
the genetic architecture of resistance to C. jejuni colon-
isation using a focussed genotyping platform. This ini-
tially involved challenge of a back-cross population (n =
288) of White Leghorn chicken inbred lines 61 and N
with C. jejuni and genotyping of the birds for 1,243 fully
informative single nucleotide polymorphism (SNP)
markers. An independent replication study was then per-
formed by challenging a 9th generation advanced inter-
cross line (AIL) population (n = 218) from a cross of the
same two inbred lines with the same C. jejuni strain and
genotyping with a 580 K SNP high density whole gen-
ome DNA array (Affymetrix® Axiom® HD) [25] to refine
and identify new quantitative trait loci (QTLs). SNP
markers significantly associated with Campylobacter
intestinal colonisation resistance were detected on
chromosomes 4, 7, 11, 14 and 16. We also performed
pathway analysis and examined gene expression and re-
sequencing data to identify candidate genes within the
relevant genomic intervals.
Results
Phenotypes for parental lines, back-cross and AIL birds
Mean values and standard deviations of log-transformed
caecal C. jejuni levels following experimental inoculation
with strain 11168H for line 61 and N parental birds, the
[(61 x N) x N] back-cross and the 9
th generation AIL
(61 x N) birds are listed in Additional file 1: Table S1.
With a single exception of low counts on third day
post-infection (dpi), no C. jejuni colonies were de-
tected by direct plating of homogenates in any bird
of resistant line 61. In contrast, significant levels of C.
jejuni colonisation were identified in susceptible line
N birds, with the number of birds showing colonisa-
tion rising over time after infection. The results are
consistent with the original report [22]. Resistance was
semi-dominant in that levels of C. jejuni in the backcross
and AIL population, measured five dpi, were intermediate
between the levels seen in the two parental lines.
Interval mapping and GWAS analysis of the back-cross
experiment
The back-cross genotypes were analysed both using
interval mapping (linkage analysis) and GWAS analysis
(linkage disequilibrium (LD) analysis). In contrast to
earlier studies [22, 23] we found with both analyses that
levels of bacteria measured in challenged birds behaved
as a quantitative trait, and mapped genetically to mul-
tiple loci. Two QTLs were detected on chromosomes 7
and 14 that were significantly associated with the log-
transformed number of C. jejuni in the caeca at 5 dpi by
the interval mapping analysis. The QTL on chromosome
7 was located at 26 Mb (Fig. 1) with a 1-LOD interval of
19.3 to 27.12 Mb. This QTL was significant at the
chromosome-wide level (P-value <0.01) and, with an F
value of 12.79, was close to genome-wide significance
(5 % F-statistic threshold = 14.73). The QTL on chromo-
some 14 at 7 Mb (1 LOD interval 2.46 to 13.25 Mb) was
significant at the chromosome-wide level (P-value <0.05)
with an F value of 7.59 (Fig. 1).
GWAS analysis, using the limited informative marker
set, identified both significant associations on chromo-
somes 7 and 14 as in the interval mapping analysis
(Table 1). In addition, one SNP on chromosome 11 was
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also significantly associated at chromosome-wide level
with the log-transformed caecal C. jejuni load (Table 1).
The significant SNPs located on chromosome 7 were in
high LD with each other (r2 = 0.89–0.98) and the same
was the case for the SNPs on chromosome 14 (r2 = 0.97).
Additional file 2: Figure S1 shows the Manhattan plot
and the Q-Q plot displaying the GWAS results.
The SNPs in all three regions were confirmed to have a
significant effect in the mixed model analysis (P-value
<0.05). The additive genetic effects of the SNPs located on
chromosome 7, 14 and 11 were log10 cfu/g 0.72 (P-value =
0.007), 0.71 (P-value = 0.006) and 0.68 (P-value = 0.009),
respectively, and the phenotypic variance explained by
these SNPs was 4.5 %, 4.3 % and 4.0 %, respectively.
GWAS analyses of the AIL experiment
Multidimensional scaling analysis (MSA) revealed five
substructure clusters in the AIL population, which were
subsequently included in the GWAS model to correct
results for population stratification.
GWAS analysis identified two SNPs significantly asso-
ciated with the log-transformed number of C. jejuni in
the caeca at 5 dpi on chromosome 14, located within the
1 LOD interval of the chromosome 14 QTL identified in
the back-cross experiment (Table 2). Thus, the QTL on
chromosome 14 was confirmed. Additionally, two SNPs
crossing the suggestive genome-wide significant thresh-
old were identified on chromosomes 4 and one SNP
reaching the chromosome-wide significant threshold on
Chromosome 7 Position (Mb)
Chromosome 14 Position (Mb)
Fig. 1 F-statistic scores obtained from least-squares interval mapping analysis in the back-cross experiment. F-statistic score of log-transformed
number of C. jejuni per gram of caecal contents is plotted against location for chromosome 7 (above) and chromosome 14 (below)
Table 1 List of SNPs associated with log-transformed caecal
Campylobacter load at 5dpi in the back-cross population
SNP name Chr Position (bp) P-value -log10(P)
Gga_rs15865889 7 25741058 4.2 × 10−4 3.38
Gga_rs14618024 7 26003071 4.9 × 10−4 3.31
Gga_rs16597361 7 24812369 6.8 × 10−4 3.17
Gga_rs15010208 14 8288336 1.3 × 10−3 2.86
Gga_rs14076550 14 8716372 2.1 × 10−3 2.68
Gga_snp-142-64-19874-S-1 11 11791311 4.2 × 10−3 2.37
SNPs highlighted bold were significant at suggestive genome-wide level
(P < 8.24 x 10−4) after Bonferroni correction
Table 2 List of SNPs associated with caecal Campylobacter
colonisation level at 5dpi in the AIL population
Phenotype SNP name Chr Position (bp) P-value -log10P
Continues Affx-50646913 14 12330355 9.09 × 10−7 6.05
Affx-50646912 14 12329892 1.87 × 10−6 5.73
Affx-51436990 4 50482802 1.61 × 10−6 5.80
Affx-51437092 4 50540614 3.07 × 10−6 5.51
Affx-50712088 16 216322 2.23 × 10−4 3.65
Binary Affx-51436990 4 50482802 1.31 × 10−7 6.88
Affx-51437092 4 50540614 5.57 × 10−7 6.25
Affx-51437128 4 50570363 6.14 × 10−7 6.21
Affx-51437052 4 50519407 1.46 × 10-6 5.83
Affx-51436951 4 50458809 2.20 × 10−6 5.65
Affx-51436911 4 50436442 2.20 × 10−6 5.65
Affx-51437087 4 50538487 2.40 × 10−6 5.62
Affx-51437031 4 50505712 3.24 × 10−6 5.49
Affx-50711743 16 159629 2.15 × 10−4 3.66
Continues: log-transformed Campylobacter load in caeca; Binary: (0/1); SNPs in
bold: significant at genome-wide (P ≤ 1.75 × 10−7) or suggestive genome-wide
(P ≤ 3.50 × 10−6) level after Bonferroni correction
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chromosome 16 (Table 2). The Manhattan plot and the
Q-Q plot for the GWAS results are displayed in Fig. 2.
The estimated additive effects for SNP markers on
chromosomes 14, 4 and 16 were log10cfu/g 1.2 (P-
value = 0.01), 1.1 (P-value = 0.04) and 2.6 (P-value =
0.0001), respectively; proportions of the total phenotypic
variance explained were 10, 9 and 6 %, respectively.
Collectively, these three loci explained 25 % of the pheno-
typic variance.
The GWAS data was also reanalysed as a binary trait.
This approach identified both the chromosome 4 and 16
significant associations with Campylobacter colonisation
status (Table 2) and the significant SNP on chromosome
4 crossed the genome-wide significance threshold
(Table 2). The Manhattan plot and the Q-Q plot for the
GWAS results from the case-control analysis are dis-
played in Additional file 3: Figure S2.
Annotation of QTL regions identified from the back-cross
and AIL experiments
The large region encompassed by the QTL on chromo-
some 7 contains a relatively small number of genes, a
total of 124 genes and 12 microRNA, inside the 1 LOD
interval region (Additional file 4: Table S2).
The significant SNP on chromosome 11 is located in
an intergenic region between two cadherin genes, cad-
herin 11 precursor (CDH11) and cadherin 8 (CDH8).
Very close to this SNP a third cadherin gene, cadherin 5
(CDH5) was located (Additional file 4: Table S2).
The two significant SNPs identified on chromosome
14 in the AIL experiment were in strong LD and
belonged to the same small LD block (154 bp)
(Additional file 5: Figure S3). The two significant SNPs
were in high LD with the other SNP markers located in
regions 0.2 Mb upstream and downstream (Additional
file 5: Figure S3). In this 0.4 Mb region, 22 genes and
two microRNAs are located (Additional file 4: Table S2).
The two significant markers were located in the intronic
region of an undescribed gene in the chicken genome.
Further investigation in the Ensembl database suggested
that this was the orthologue of the N-acetyltransferase
15 (NAT15) gene in humans.
The significant SNPs on chromosome 4 were in high
LD and located in a very small LD block (Additional file
6: Figure S4). These SNPs were also in high LD with
SNP markers located in regions 0.2 Mb upstream and
downstream (Additional file 6: Figure S4). In this 0.4 Mb
region, five annotated genes and two microRNAs are
located (Additional file 4: Table S2); all significant SNPs
were located in the intronic region of the Ephrin recep-
tor A5 (EPHA5) gene.
The significant SNP on chromosome 16 was located
inside a single LD block with a length of 224 Kb and
was in high LD with the other SNPs located there
0 5 10 15 20 25
Expected X 2
0
5
10
15
20
25
O
bs
er
ve
d 
X
 2
Fig. 2 Manhattan plot and Q-Q plot displaying the GWAS results from the AIL experiment (continuous phenotypes). Genomic location is plotted
against -log10(P) in the Manhattan plot (above). Genome-wide (P < 0.05) and suggestive genome-wide thresholds are shown as dashed lines. Q–Q
plot (below) of observed P-values against the expected P-values for Campylobacter gut colonisation (log-transformed number of C. jejuni per gram
of caecal contents)
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(Additional file 7: Figure S5). This region contains 29 an-
notated genes most of which are related in the Major
Histocompatibility Complex (MHC) (Additional file 4:
Table S2).
Re-sequencing data analysis of back-cross and AIL results
To identify possible protein-coding genes associated
with the detected QTLs, the genomic sequences of lines
61 and N birds in the regions of interest were compared.
The focus was on the identification of exonic single nu-
cleotide variants (SNVs) with high importance (i.e., non-
sense (stop-gain) and missense (non-synonymous)
exonic and splicing), since these can affect the function
of the gene leading to different isoforms of the tran-
scribed proteins. Genomic regions located within 1 kb
upstream of the respective genes were also analysed to
identify SNVs with a potential regulatory effect. Due to
the lack of regulatory element annotation in chickens,
we developed our own pipeline for identifying possible
regulatory site mutations. The 1 kb upstream genomic
regions were scanned for putative TATA box and CpG
island motifs. TATA boxes help facilitate transcription
factor binding [26] thus TATA box mutations can effect
transcription rates. CpG islands play an important role
in methylation regulatory pathways [27]. CpG islands are
characterised by regions which have a high density of
CpG sites that can be methylated to down-regulate gene
expression. Thus mutations in CpG sites can alter tran-
scription regulation.
Summary statistics of all the SNVs identified in the
candidate regions for Campylobacter colonisation resist-
ance and all the SNVs detected, the Variant Effect Pre-
dictor annotation and the SIFT predictions are
presented in Additional file 8: Figure S6 and Additional
file 9: Table S3, respectively. In total, 20,125 variants
were identified. The SNVs located in exonic regions
were in total less than 5 % while the rest of the SNVs
(95 %) were located in intronic, upstream and down-
stream regions. A few genes with SNVs that potentially
could lead to non-functional transcripts were detected.
More specifically, two genes AXIN 1 located on chromo-
some 14 and BG1 on chromosome 16 were found to
contain a stop-gain SNV, a sequence variant whereby at
least one base of a codon is changed, resulting in a pre-
mature stop codon, leading to a shortened transcript;
three genes, BG1 and ENSGALG00000028367 located
on chromosome 16 and CCDC108 on chromosome 7
contained a splice acceptor variant, a splice variant that
changes the 2 base region at the 3' end of an intron and
might lead to splicing changes; two genes, RACGAP1
and SPEG on chromosome 7 contained a splice donor
variant, a splice variant that changes the 2 base region at
the 5' end of an intron and can lead to splicing changes,
as well. Furthermore, seventeen genes contained
missense and according to SIFT prediction deleterious
SNVs that might create partially or completely non-
functional proteins. More specifically, C16orf96 gene on
chromosome 14, C4, BFIV21, B-BTN2, TAP2 and IL4I1
on chromosome 16, IFIH1, LY75, SLC11A1, SLC38A11,
SPEG, ZNF142, CCDC108, TTC21B, OBSL1, PTPRN,
GLB1L on chromosome 7 had missense deleterious
SNVs. Several other genes contained SNVs with moder-
ate impact. Details of genes containing splicing, 5′ UTR,
both missense and UTR SNVs are presented in
Additional file 10: Table S4.
TATA box motifs were identified in the upstream re-
gion of some genes but no variation was detected there.
On the other hand, CpG island motifs were detected in
many of the genes studied and some had SNVs. How-
ever, only in few cases the SNVs occur in CpG sites. De-
tails of the genes containing SNVs in CpG sites are
presented in the Additional file 10: Table S4.
The gene transcript from each experiment with the
highest rate of non-synonymous coding SNVs (i.e., num-
ber of non-synonymous SNVs divided by the length of
the coding DNA sequence (CDS) of the transcript, dN/L),
rate of non-synonymous to synonymous SNVs (dN/dS),
rate of exonic SNVs (number of exonic SNVs divided by
exonic length of the transcript), rate of intronic SNVs
(number of intronic SNVs divided by intronic length of
the transcript) are presented in Table 3. These rates were
considered to pertain to transcripts that differed between
the two parental lines and an indication of positive selec-
tion that might result in the creation of different alleles
responsible for functional differences in immune re-
sponses affecting disease resistance in the two lines.
Ingenuity pathway analysis of back-cross and AIL results
To identify potential canonical pathways and networks
underlying the QTLs detected, we performed pathway
analysis using the genes located in these regions. Path-
ways involved in innate and adaptive immune response,
inflammatory response, response to infectious diseases,
cell signalling and adhesion, and metabolism constituted
the majority of the pathways highlighted for both back-
cross and AIL results (Fig. 3). Moreover, two networks
of molecular interactions related to immune response
were constructed using the list of candidate genes for
AIL (Additional file 11: Figure S7).
Gene expression analysis
Many quantitative traits are associated with altered gene
expression rather than coding variation. For example,
variable expression of the satiety signal receptor,
CCKAR, is associated with appetite control in chickens
[28]. Two chemokine genes, CXCLi1 and CXCLi2, lie in
close proximity with the significant markers identified
on chromosome 4. Both chemokines are induced after
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Table 3 Genes and transcripts located in the QTL candidate regions for Campylobacter resistance with the highest variation among
the two parental lines. (A) Backcross experiment (B) Advanced Intercross Experiment
Gene Transcript Chr dN/dS dN/L exon_rate intron_rate
A
ENSGALG00000026721 ENSGALT00000043718 7 3 0.002441 0.003247 No introns
FAM134A ENSGALT00000018495 7 3 0.002098 0.002797 0.006759
RALB ENSGALT00000018997 7 3 0.004342 0.00519 0.00601
IFIH1 ENSGALT00000018067 7 2 0.000608 0.000743 0.000568
ARPC2 ENSGALT00000018675 7 2 0.001768 0.002418 0.003158
PECR ENSGALT00000018735 7 2 0.002235 0.003007 0.006175
LZTR1 ENSGALT00000046043 7 2 0.002436 0.003925 0.003483
NIFK ENSGALT00000019039 7 2 0.002424 0.002251 0.006897
CCDC14 ENSGALT00000019150 7 2 0.000729 0.001017 0.004697
TTC21B ENSGALT00000038446 7 1.75 0.001702 0.002346 0.004126
SMARCAL1 ENSGALT00000018709 7 1.333333 0.001388 0.004471 0.005288
C16orf96 ENSGALT00000042897 14 1.25 0.008818 0.014139 0.00646
COBLL1 ENSGALT00000018021 7 1.2 0.001736 0.003179 0.003251
OBSL1 ENSGALT00000018337 7 1.142857 0.002852 0.00482 0.009001
SLX4 ENSGALT00000046089 14 1 0.001744 0.004729 0.005968
SLC38A11 ENSGALT00000018002 7 1 0.000749 0.003485 0.007136
FIGN ENSGALT00000018023 7 1 0.000446 0.000892 No introns
FAP ENSGALT00000018083 7 1 0.000444 0.001297 0.002828
ASIC4 ENSGALT00000018356 7 1 0.001254 0.002503 0.008669
ZFAND2B ENSGALT00000044043 7 1 0.002137 0.004343 0.007585
SLC11A1 ENSGALT00000018510 7 1 0.00119 0.002381 0.009314
C16orf96 ENSGALT00000042897 14 1.25 0.008818 0.014139 0.00646
ENSGALG00000023695 ENSGALT00000039593 14 NA 0.005587 0.00534 0.002789
RALB ENSGALT00000018997 7 3 0.004342 0.00519 0.00601
GJD3 ENSGALT00000018322 7 NA 0.003421 0.003421 0.008052
OBSL1 ENSGALT00000018337 7 1.142857 0.002852 0.00482 0.009001
ENSGALG00000026721 ENSGALT00000043718 7 3 0.002441 0.003247 No introns
LZTR1 ENSGALT00000046043 7 2 0.002436 0.003925 0.003483
NIFK ENSGALT00000019039 7 2 0.002424 0.002251 0.006897
ENSGALG00000023707 ENSGALT00000039621 14 0.285714 0.002304 0.010333 0.008303
CCDC108 ENSGALT00000018523 7 0.75 0.002268 0.005093 0.009366
PECR ENSGALT00000018735 7 2 0.002235 0.003007 0.006175
TMEM169 ENSGALT00000038136 7 1 0.002176 0.003236 0.007113
ZFAND2B ENSGALT00000044043 7 1 0.002137 0.004343 0.007585
FAM134A ENSGALT00000018495 7 3 0.002098 0.002797 0.006759
CYP27A1 ENSGALT00000003899 7 0.75 0.001911 0.004882 0.003762
RACGAP1 ENSGALT00000018359 7 0.6 0.001808 0.004455 0.007782
NHEJ1 ENSGALT00000018498 7 1 0.001795 0.011236 0.006046
ARPC2 ENSGALT00000018675 7 2 0.001768 0.002418 0.003158
SLX4 ENSGALT00000046089 14 1 0.001744 0.004729 0.005968
COBLL1 ENSGALT00000018021 7 1.2 0.001736 0.003179 0.003251
C16orf96 ENSGALT00000042897 14 1.25 0.008818 0.014139 0.00646
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Table 3 Genes and transcripts located in the QTL candidate regions for Campylobacter resistance with the highest variation among
the two parental lines. (A) Backcross experiment (B) Advanced Intercross Experiment (Continued)
MNR2 ENSGALT00000018518 7 0 0 0.012723 0.00565
NHEJ1 ENSGALT00000018498 7 1 0.001795 0.011236 0.006046
TUBA4A ENSGALT00000018477 7 0 0 0.010549 0.004069
ENSGALG00000023707 ENSGALT00000039621 14 0.285714 0.002304 0.010333 0.008303
TUBA4A ENSGALT00000038318 7 0.058824 0.000729 0.010204 0.017134
HSPBAP1 ENSGALT00000019085 7 0.25 0.001374 0.006512 0.006158
C2orf62 ENSGALT00000029291 7 0.166667 0.000938 0.006416 0.008264
ABCB6 ENSGALT00000038272 7 0.2 0.000805 0.006006 0.007832
ERCC3 ENSGALT00000018775 7 0 0 0.005964 0.01652
PLA2R1 ENSGALT00000033111 7 0.5 0.00138 0.005762 0.008359
STK16 ENSGALT00000018480 7 0 0 0.005722 0.006693
ENSGALG00000023695 ENSGALT00000039593 14 NA 0.005587 0.00534 0.002789
GLB1L ENSGALT00000018482 7 0.5 0.001586 0.005227 0.012599
RALB ENSGALT00000018997 7 3 0.004342 0.00519 0.00601
CCDC108 ENSGALT00000018523 7 0.75 0.002268 0.005093 0.009366
CYP27A1 ENSGALT00000003899 7 0.75 0.001911 0.004882 0.003762
EPB41L5 ENSGALT00000018952 7 0 0 0.004822 0.006925
OBSL1 ENSGALT00000018337 7 1.142857 0.002852 0.00482 0.009001
SPEG ENSGALT00000043042 7 0.194444 0.000763 0.004805 0.005843
TUBA4A ENSGALT00000038318 7 0.058824 0.000729 0.010204 0.017134
ERCC3 ENSGALT00000018775 7 0 0 0.005964 0.01652
GLB1L ENSGALT00000018482 7 0.5 0.001586 0.005227 0.012599
RUFY4 ENSGALT00000043062 7 0.333333 0.001133 0.003315 0.01241
ATG9A ENSGALT00000019038 7 0 0 0.002891 0.011987
RPL37A ENSGALT00000018702 7 0 0 0 0.011268
C16orf5 ENSGALT00000012346 14 0 0 0.002632 0.011263
AAMP ENSGALT00000018663 7 0 0 0.001614 0.010427
DES ENSGALT00000018446 7 0 0 0.003731 0.010335
CTDSP1 ENSGALT00000045561 7 0 0 0.001002 0.010093
ANKZF1 ENSGALT00000018493 7 0 0 0.004431 0.010028
IGFBP2 ENSGALT00000018698 7 0 0 0.003279 0.009894
CCDC108 ENSGALT00000018523 7 0.75 0.002268 0.005093 0.009366
SLC23A3 ENSGALT00000018510 7 1 0.00119 0.002381 0.009314
OBSL1 ENSGALT00000018337 7 1.142857 0.002852 0.00482 0.009001
ASIC4 ENSGALT00000018356 7 1 0.001254 0.002503 0.008669
LY75 ENSGALT00000018187 7 0.266667 0.000775 0.00358 0.008563
PLA2R1 ENSGALT00000033111 7 0.5 0.00138 0.005762 0.008359
ENSGALG00000023707 ENSGALT00000039621 14 0.285714 0.002304 0.010333 0.008303
C2orf62 ENSGALT00000029291 7 0.166667 0.000938 0.006416 0.008264
ARHGEF1 ENSGALT00000045992 7 0 0 0.002606 0.008085
B
Gene Transcript Chr dN/dS dN/L exon rate intron rate
BF2 ENSGALT00000046170 16 9 0.00878 0.009381 0.010121
BF2 ENSGALT00000000139 16 9 0.00885 0.009452 0.01004
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Table 3 Genes and transcripts located in the QTL candidate regions for Campylobacter resistance with the highest variation among
the two parental lines. (A) Backcross experiment (B) Advanced Intercross Experiment (Continued)
BF2 ENSGALT00000044107 16 9 0.00858 0.013504 0.010373
BF2 ENSGALT00000043207 16 9 0.008515 0.013432 0.01046
RASSF6 ENSGALT00000019068 4 2 0.001974 0.005961 0.006711
BLB1 ENSGALT00000008925 16 2 0.002994 0.002985 0
TRIM27 ENSGALT00000000172 16 1.666667 0.003915 0.006672 0.007874
TAPBP ENSGALT00000000203 16 1.333333 0.00312 0.005109 0.010619
C16orf96 ENSGALT00000042897 14 1.25 0.008818 0.014139 0.00646
TNXB ENSGALT00000000238 16 1.25 0.002016 0.003629 0.001132
SLX4 ENSGALT00000046089 14 1 0.001744 0.004729 0.005968
TAPBP ENSGALT00000044889 16 1 0.002132 0.003899 0.010359
SLX4 ENSGALT00000012367 14 0.875 0.001439 0.004358 0.006141
ENSGALG00000028367 ENSGALT00000045620 16 0.75 0.002477 0.00578 0.013439
TAP2 ENSGALT00000000237 16 0.666667 0.00382 0.009537 0.014909
BG1 ENSGALT00000045385 16 0.6 0.005976 0.016882 0.010126
TRAP1 ENSGALT00000012459 14 0.5 0.000965 0.003201 0.007825
HLADMB ENSGALT00000041213 16 0.5 0.002865 0.008137 0.006479
TCLEC2D ENSGALT00000000183 16 0.5 0.001789 0.005938 0.011905
TRIM41 ENSGALT00000045935 16 0.5 0.001744 0.004208 0.00173
TRIM27 ENSGALT00000042650 16 0.5 0.000892 0.002676 0.003241
BNK ENSGALT00000000188 16 NA 0.013462 0.011445 0.003878
BF2 ENSGALT00000000139 16 9 0.00885 0.009452 0.01004
C16orf96 ENSGALT00000042897 14 1.25 0.008818 0.014139 0.00646
BF2 ENSGALT00000046170 16 9 0.00878 0.009381 0.010121
BF2 ENSGALT00000044107 16 9 0.00858 0.013504 0.010373
BF2 ENSGALT00000043207 16 9 0.008515 0.013432 0.01046
BG1 ENSGALT00000045385 16 0.6 0.005976 0.016882 0.010126
ENSGALG00000023695 ENSGALT00000039593 14 NA 0.005587 0.00534 0.002789
TRIM27 ENSGALT00000000172 16 1.666667 0.003915 0.006672 0.007874
TAP2 ENSGALT00000000237 16 0.666667 0.00382 0.009537 0.014909
ZNF692 ENSGALT00000031515 16 0.454545 0.003215 0.00949 0.01307
Hep21 ENSGALT00000000164 16 NA 0.003145 0.00316 0.008
TAPBP ENSGALT00000000203 16 1.333333 0.00312 0.005109 0.010619
BLB1 ENSGALT00000008925 16 NA 0.002994 0.002985 0
HLADMB ENSGALT00000041213 16 0.5 0.002865 0.008137 0.006479
DMB2 ENSGALT00000000222 16 0.4 0.002581 0.010393 0.014409
ENSGALG00000028367 ENSGALT00000045620 16 0.75 0.002477 0.00578 0.013439
ENSGALG00000023707 ENSGALT00000039621 14 0.285714 0.002304 0.010333 0.008303
TAPBP ENSGALT00000044889 16 1 0.002132 0.003899 0.010359
TNXB ENSGALT00000000238 16 1.25 0.002016 0.003629 0.001132
RASSF6 ENSGALT00000019068 4 2 0.001974 0.005961 0.006711
BG1 ENSGALT00000045385 16 0.6 0.005976 0.016882 0.010126
C16orf96 ENSGALT00000042897 14 1.25 0.008818 0.014139 0.00646
BF2 ENSGALT00000044107 16 9 0.00858 0.013504 0.010373
BF2 ENSGALT00000043207 16 9 0.008515 0.013432 0.01046
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Campylobacter infection in chickens [8, 12, 29] and
might be involved in effective host immune response. We
therefore examined their expression in caecal tonsils of
challenged birds. The data are shown in Additional file 12:
Figure S8. Data are expressed as the fold change in mRNA
levels when samples from infected birds were compared
to non-infected birds of the same age from each line. In C.
jejuni infected birds from both lines CXCLi1 and CXCLi2
were down-regulated. Nevertheless, the level of che-
mokine CXCLi2 was decreased in line N significantly
(P-value <0.05) more than in line 61, while CXCLi1
levels did not significantly differ between the lines.
Table 3 Genes and transcripts located in the QTL candidate regions for Campylobacter resistance with the highest variation among
the two parental lines. (A) Backcross experiment (B) Advanced Intercross Experiment (Continued)
BNK ENSGALT00000000188 16 NA 0.013462 0.011445 0.003878
DMB2 ENSGALT00000000222 16 0.4 0.002581 0.010393 0.014409
ENSGALG00000023707 ENSGALT00000039621 14 0.285714 0.002304 0.010333 0.008303
TAP2 ENSGALT00000000237 16 0.666667 0.00382 0.009537 0.014909
LOC422654 ENSGALT00000041397 4 0 0 0.009533 0
ZNF692 ENSGALT00000031515 16 0.454545 0.003215 0.00949 0.01307
BF2 ENSGALT00000000139 16 9 0.00885 0.009452 0.01004
BF2 ENSGALT00000046170 16 9 0.00878 0.009381 0.010121
HLADMB ENSGALT00000041213 16 0.5 0.002865 0.008137 0.006479
DMB2 ENSGALT00000041214 16 0 0 0.008121 0.011547
TAP1 ENSGALT00000045907 16 0.230769 0.001726 0.006978 0.010147
TRIM27 ENSGALT00000000172 16 1.666667 0.003915 0.006672 0.007874
IL4I1 ENSGALT00000000109 16 0.428571 0.001912 0.006361 0.005435
RASSF6 ENSGALT00000019068 4 2 0.001974 0.005961 0.006711
TCLEC2D ENSGALT00000000183 16 0.5 0.001789 0.005938 0.011905
ENSGALG00000028367 ENSGALT00000045620 16 0.75 0.002477 0.00578 0.013439
TAP2 ENSGALT00000000237 16 0.666667 0.00382 0.009537 0.014909
DMB2 ENSGALT00000000222 16 0.4 0.002581 0.010393 0.014409
ENSGALG00000028367 ENSGALT00000045620 16 0.75 0.002477 0.00578 0.013439
ZNF692 ENSGALT00000031515 16 0.454545 0.003215 0.00949 0.01307
TCLEC2D ENSGALT00000000183 16 0.5 0.001789 0.005938 0.011905
DMB2 ENSGALT00000041214 16 0 0 0.008121 0.011547
CXCLi1 ENSGALT00000019072 4 0 0 0.001606 0.011457
C16orf5 ENSGALT00000012346 14 0 0 0.002632 0.011263
TAPBP ENSGALT00000000203 16 1.333333 0.00312 0.005109 0.010619
BF2 ENSGALT00000043207 16 9 0.008515 0.013432 0.01046
BF2 ENSGALT00000044107 16 9 0.00858 0.013504 0.010373
TAPBP ENSGALT00000044889 16 1 0.002132 0.003899 0.010359
TAP1 ENSGALT00000045907 16 0.230769 0.001726 0.006978 0.010147
BG1 ENSGALT00000045385 16 0.6 0.005976 0.016882 0.010126
BF2 ENSGALT00000046170 16 9 0.00878 0.009381 0.010121
BF2 ENSGALT00000000139 16 9 0.00885 0.009452 0.01004
BMA1 ENSGALT00000000214 16 0.25 0.001274 0.005488 0.010015
C4 ENSGALT00000044830 16 0.421053 0.001616 0.005525 0.008507
DNASE ENSGALT00000039621 14 0.285714 0.002304 0.010333 0.008303
TRAP1 ENSGALT00000012459 14 0.5 0.000965 0.003201 0.007825
RASSF6 ENSGALT00000019068 4 2 0.001974 0.005961 0.006711
Non synonymous SNVs/synonymous SNVs(dN/dS); non synonymous SNVs/CDS length (dN/L); NA = no synonymous SNV present; with bold is the rate based on
which the genes were ranked
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Selection of candidate genes
A total of 20 genes were selected amongst all genes lo-
cated in the regions of interest identified from the ana-
lysis of the back-cross and AIL populations as good
candidate genes for avian resistance to Campylobacter
colonisation (Additional file 13: Table S5). Gene selec-
tion was based on their biological function, proximity to
significant markers, sequencing differences, mRNA
expression (tested for CXCLi1 and CXCLi2) after Cam-
pylobacter infection, their involvement in immune
response pathways and networks, and any previously
known involvement in other infectious diseases in
poultry (Additional file 9: Table S4).
Discussion
The present study indicates that the precise level of
Campylobacter intestinal colonisation is a heritable com-
plex quantitative trait under the genetic control of mul-
tiple loci, genes and linked sequence variants. In the
back-cross analysis we identified candidate QTLs in
three genomic locations on chromosomes 7, 11 and 14.
Using a 9th generation AIL population we refined the lo-
cation of the QTL identified on chromosome 14 (from a
12 Mb region to a 0.4 Mb region) and detected two add-
itional QTLs located on chromosomes 4 and 16. The
initial candidate regions identified in the back-cross ex-
periment have limited resolution and the detected QTLs
may reflect the effect of many linked variants which are
separated when the LD blocks break after many genera-
tions of recombination [30]. The identification of new
QTLs in the AIL analysis could be attributed to geno-
typing based on many more markers (approximately
300,000 compared to 1,300 in the back-cross experi-
ment), which considerably increased the power of QTL
detection.
Two good candidate genes, TRAP 1 and AXIN 1 were
identified in the refined QTL location on chromosome
14; this exemplifies the common findings from the two
Fig. 3 Pathway analysis using the IPA software. The most highly represented canonical pathways of genes located at the candidate regions for
Campylobacter colonisation resistance derived from the back-cross (above) and the advance intercross line (below) experiments. The solid yellow
line represents the significance threshold. The line with squares represents the ratio of the genes represented within each pathway to the total
number of genes in the pathway
Psifidi et al. BMC Genomics  (2016) 17:293 Page 10 of 18
experimental designs (back-cross and AIL). TRAP1 is
coding for a mitochondrial heat shock protein with anti-
oxidant and anti-apoptotic functions [31, 32]. Our re-
sequencing data revealed that TRAP1 is divergent be-
tween the two lines. It has a high SNV/L and dN/dS rate
that may affect its function and also has 3′/5′ UTR SNV
that may impact on gene expression. AXIN 1, is coding
for a scaffolding protein controlling the levels of β-
catenin, which in turn regulates NF-kB activity. This
gene is also very divergent in the two lines with a stop/
coding SNV, a high dN/L and dN/dS rate as well as
UTR SNV.
The two parental lines, 61 and N, have a different
MHC haplotype, B2 and B21, respectively. Therefore,
the involvement of MHC, a genomic region that encodes
molecules that provide the context in which T cells
recognize foreign antigens, in Campylobacter colonisa-
tion resistance, is not unexpected. This genomic region
is the focus of considerable interest because of the
strong, reproducible infectious disease associations
found with specific MHC haplotypes [33–36]. However,
the highly polymorphic nature of the genes, the strong
LD that exists within this region [37–39], and the lim-
ited number of SNP markers on chromosome 16 present
obstacles to associating individual genes with disease re-
sponses. The previous study of the inbred lines sug-
gested that MHC was not involved [22], but this was
based on only 41 back-cross (between lines 61 and N)
birds and the genotyping was performed using only one
microsatellite marker located close to the MHC. The
study of Boyd et al. inferred autosomal dominance at a
single locus, but that conclusion was based upon the
failure to detect the differential colonisation between the
parent line 61 and crossed birds [22].
As noted in the introduction, the only previous GWAS
study of Campylobacter intestinal colonisation resistance
in chickens [23], identified a risk locus on chromosome
11 associated with the T-cadherin (CDH13) gene. This
finding might be linked to the cadherin genes (CDH5,
CDH11, CDH8) identified in our back-cross analysis.
Cadherins are a super-family of calcium-dependent pro-
teins, with a significant role in cell-cell adhesion and the
maintenance of structural and functional tissue integrity
[40]. The cadherins might interact with C. jejuni and
consequentially affect resistance to colonisation either by
facilitating internalisation or inciting a protective host
response [41–44].
Connell et al. examined gene expression of caeca tis-
sue from high colonised and nil colonised birds of the
same breed challenged with Campylobacter, and found
evidence of more rapid innate immune response to the
infection in nil colonised birds [14]. Among the candi-
dates genes identified in the current study, there are two
genes associated with two major pro-inflammatory
chemokines (CXCLi1 and CXCLi2) that are reportedly
induced during Campylobacter infection both in chick-
ens and humans [45, 46]. Stimulated heterophils pro-
duce CXCLi1 and CXCLi2 to induce leukocyte (primarily
heterophil) chemotaxis [47, 48]. Re-sequencing data ana-
lysis of the two parental inbred lines (61 and N) revealed
no protein-coding variation, but did identify an SNV in
the 3′UTR of CXCLi2. Although SNV located in the
regulatory regions of individual genes are of high im-
portance, relevant knowledge in chickens is very limited
and literature virtually non-existent. Whether this par-
ticular variant or more distal control elements are re-
sponsible, direct measurement of mRNA levels in caecal
tonsils of infected birds confirmed differential expression
of CXCLi2 between the two lines. Similarly, Connell et
al. detected a differential expression only for CXCLi2
[14]. According to these results CXCLi2 may plausibly
contribute to resistance to Campylobacter colonisation
in chickens.
A previous study of SNP associations with innate and
adaptive immune responses in laying hens identified a
QTL on chromosome 7 at the same region where the
peak of our QTL on the same chromosome is located,
associated with complement activity [49]. Several other
innate immune genes, very different at sequence level
between the two inbred lines, lie under the peak of our
identified QTL within the 1 LOD-drop confidence
interval. The interferon-induced helicase C domain-
containing protein 1 (IFIH1) gene with a predicted spli-
cing SNV is located at 20.5 Mb, the lymphocyte antigen
75 precursor (LY75) gene, also known as CD205, which
encodes a receptor on dendritic cells, is located at
21.5 Mb. The natural resistance-associated macrophage
protein 1 (NRAMP1) gene, also known as SLC11A1, lo-
cated at 22 Mb, is another potentially exciting candidate
gene to explain this QTL. NRAMP1 regulates intracellu-
lar pathogen proliferation and macrophage inflammatory
responses, by influencing the phagolysosomal function
of macrophages. Variants in this gene have been associ-
ated with resistance to Salmonella infection in mice and
poultry [50, 51]. Interestingly, host resistance to C. jejuni
infection in the mouse is also NRAMP1-dependent [52].
Inbred lines 61 and N are resistant and susceptible re-
spectively not only to Campylobacter gut colonisation,
but also to Salmonella gut colonisation, supporting
speculation that the genetic control of colonisation
could be at least partly common for these bacteria [53].
Extensive QTL mapping studies have taken place to iden-
tify loci for resistance to S. enterica serovar Typhimur-
ium and Enteritidis colonisation over the last 20 years
using these two inbred chicken lines [2, 20, 51, 54, 55].
Interestingly, two QTLs for resistance to enteric carriage
of Salmonella have been identified at the same regions
on chromosome 14 [54] and 16 [51, 55] as in our study.
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Both TRAP1 and AXIN 1, the two putative candidate
genes on chromosome 14 for Campylobacter colonisa-
tion resistance, have been also associated with Salmon-
ella infection in previous studies [56, 57].
Line 61 is also resistant to infectious bursal disease
virus (IBDV) and Marek’s disease virus (MDV) while line
N is resistant to infectious bronchitis virus (IBV) and
MDV. Whole-genome gene expression analyses compar-
ing resistant line 61 with susceptible inbred line 7 for
MDV and inbred Brown Leghorn [Brl] line for IBDV
have been conducted to investigate the host response to
these infections [58–63]. Likewise, similar analysis com-
paring resistant line N with susceptible inbred line 15I
for IBV has been conducted. Among the genes
highlighted as candidate genes for IBV, IBDV or MDV
resistance, with different expression during the host re-
sponse and differential expression between the resistant
and susceptible lines, were many of the genes identified
in our study as good candidates for Campylobacter
intestinal colonisation resistance (Additional file 13:
Table S5). These genes may play a central role in an
overall effective host immune response.
Conclusion
The multiple QTLs identified as well as the many im-
mune response and inflammation pathways and the pre-
dicted involvement of MHC attest to a complex trait
controlled by many candidate genes each with a moder-
ate or weak effect. However, the magnitude of the addi-
tive effect size of the significant markers and the large
proportion of the phenotypic variance explained by them
is encouraging for informing breeding strategies for en-
hanced Campylobacter colonisation resistance in broiler
chicken. A study by Gormley et al. revealed that levels of
contamination generated by natural exposure varied by
at least two orders of magnitude in a wide range of com-
mercial broiler genotypes [64]. As our findings pertain
to inbred lines and linkage disequilibrium will likely be
different in outbred broiler populations future research
is now warranted to explore the genetic basis for resist-
ance in commercial birds and extent of variation at the
QTLs identified. Our study highlights the utility of using
inbred lines as a resource to map resistance-associated
loci, gaining increased power to detect QTLs with mod-
est effects, and informs the design of selective breeding
strategies for control of a major zoonosis.
Methods
Ethical statement
All animal experiments were conducted in accordance
with the Animals (Scientific Procedures) Act 1986, with
the approval of the Ethical Review Committee of The
Pirbright Institute (under project licence PPL 30/2462)
and the Animal Welfare and Ethical Review Body of The
Roslin Institute (under PPL 60/4420).
Animals
Chicken inbred lines 61 (resistant to Campylobacter
colonisation) and N (susceptible to Campylobacter col-
onisation) were originally derived from White Leghorn
flocks at the USDA-ARS Avian Disease and Oncology
Laboratory in East Lansing, MI, USA. The lines have
been maintained by random mating within the
specified-pathogen-free (SPF) flocks at the Pirbright
Institute in the UK since 1972 (line 61) and 1982 (line
N). To generate the back-cross (n = 288 for the
present study), F1 progeny (61 x N) were crossed with
the susceptible line N.
Colonies of lines 61 and N were given to INRA Tours
by the Pirbright Institute over a decade ago. A 9th gener-
ation AIL between lines 61 and N was generated there.
At each generation, animals from distinct families were
crossed to minimise inbreeding and increase the number
of recombinations as suggested by Darvasi and Soller
[65]. In total, 218 AIL birds were generated for the
present study.
Bacterial challenge
In the parent lines, back-cross and AIL, day-old birds
were orally inoculated with 0.1 ml of an overnight
Mueller-Hinton broth culture of Campylobacter-free gut
flora originally taken from the caecal contents of an
adult SPF chicken. Birds were orally challenged at three
weeks of age with 108 CFU C. jejuni strain 11168H, a
hypermotile variant of the sequenced strain NCTC11168
that readily colonises chickens [66] or with control
Mueller-Hinton medium only. To confirm resistance or
susceptibility to Campylobacter colonisation, control
birds (n = 4–5 per line) and infected birds (n = 8–10 per
line) were killed at 2, 3, 4 and 5 dpi and a sample of cae-
cal contents was obtained. In addition, caecal tonsil sam-
ples of the birds killed 5 dpi were removed to RNAlater
for RNA extraction, and gene expression analysis, as
described below. Three separate challenge experiments
were performed for logistical reasons on the back-cross
and AIL populations to assess the level of Campylobac-
ter colonisation in which birds were killed at 5 dpi and
caecal contents were removed to measure the Campylo-
bacter load and blood samples were taken for DNA
extraction and genotyping, as described below.
Phenotyping
The level of bacterial colonisation in the caecal contents
of infected birds was determined in all birds from the
back-cross and AIL populations as well as the respective
parents as described previously [67]. Bacterial counts for
both the back-cross and AIL population were skewed
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and were accordingly log-transformed in order to nor-
malise their distribution. Thus, phenotypes were
expressed on a continuous scale as log-transformed bac-
terial counts. Moreover, in the case of AIL the pheno-
types were also expressed on a binary (0/1) scale
indicating absence or minimal colonisation (i.e., no col-
onies detected by direct plating of 0.1 g homogenate;
thus corresponding to birds with Campylobacter load ≤
100 CFU/g of content)/presence of colonisation.
Genotyping and QTL detection
This part of the study was conducted as two separate
experiments described below.
Back-cross experiment
QTL mapping analysis
Over 18,000 genome-wide SNPs were screened in the
parent lines (61 and N) to identify fully informative
markers for the back-cross mapping study. All SNPs
were available through Ensembl (www.ensembl.org) and
were analysed using existing panels of chicken SNPs.
Markers were selected in the parent lines on the basis of
their fixation for the alternate allele at each position,
providing maximum information content in the back-
cross population. A total of 1,385 SNPs were selected
from the 18,000 SNPs panel for analysis in the present
study. Genotyping and quality control were performed
as described before [20]. A full list of the SNPs (1,243)
used in the final analysis is displayed in Additional file
14: Table S6. Positions of SNP markers were obtained
using the Gal-gal4 assembly in Ensembl Genome
Browser (www.ensembl.org).
QTL analysis was performed by regression interval
mapping [68] using the QTL Express software [69] avail-
able through GRIDQTL (http://gridqt1.cap.ed.ac.uk) as
described previously [20].
GWAS analysis
The back-cross genotypes were also analysed in a GWAS
in order to compare with and validate interval mapping
results. The following thresholds were used for quality
control: minor allele frequency (MAF) < 0.05 and call
rate > 95 %. Deviation from Hardy-Weinberg equilibrium
was not considered as a criterion for excluding SNPs
since this was a back-cross population. After the quality
control, 1,212 SNP markers remained for further ana-
lysis. The software GEMMA [70] was used to run the
GWAS analysis using a standard univariate linear mixed
model in which sex (male, female) and experiment num-
ber (1, 2, 3) were fitted as fixed effects and the genomic
relationship matrix among individuals was included as a
random effect. A Bonferroni correction was applied for
multiple testing [71]. After Bonferroni correction, signifi-
cance thresholds were P ≤ 4.12 × 10−5 and P ≤ 8.24 × 10−4
for genome-wide (P ≤ 0.05) and suggestive (namely
one false positive per genome scan) levels, corre-
sponding to -log10(P) of 4.38 and 3.08, respectively.
Searches for significant SNPs were performed also at
chromosome-wide level (P ≤ 0.05).
SNP validation
Individual markers found to be significant in GWAS
were further verified in an association analysis where
each SNP was fitted as a fixed effect simultaneously with
other fixed effects previously fitted (in the GWAS ana-
lysis) in a mixed model. The analysis was carried out
with the software ASREML [72]. This analysis yielded
estimates of the magnitude of the additive SNP effect, as
the difference in value between the homozygous (line N-
AA) and the heterozygous (AB) genotypes. Solutions
were the predicted trait values for each genotype class.
Finally, to evaluate the extent of LD and identify po-
tential regions of causal mutations for Campylobacter
colonisation resistance, LD among SNPs was calculated
as an r-square value using the software Plink [73]. Fur-
thermore, LD blocks in the regions where significant
SNPs were found with GWAS were visualised using the
software Haploview [74].
Advanced intercross line experiment
GWAS
AIL birds were genotyped using a 580 K SNP high dens-
ity whole genome SNP array (Affymetrix® Axiom® HD)
[74]. The SNP genotype data were subjected to quality
control measures using the following thresholds: MAF <
0.02 and call rate < 95 %. Deviation from Hardy-
Weinberg equilibrium was not considered as a method
for excluding SNPs since this was an AIL population.
After quality control, 286,432 SNP markers remained for
further analysis. Positions of SNP markers were obtained
using the Gal-gal4 assembly in Ensembl Genome
Browser (www.ensembl.org).
The phenotypes were treated both as continuous and
as binary data (based on a case-control model). In the
case of the binary analysis, 133 birds with no or minimal
colonisation where considered as controls and the
remaining 85 birds were considered as cases.
The AIL data was analysed using GWAS. To investi-
gate any population stratification present in the popula-
tion, a genomic relationship matrix was generated from
all individuals. This genomic relationship matrix was
converted to a distance matrix that was used to carry
out classical MSA. All analyses of population stratifica-
tion were performed using GenABEL software [75]. The
same software and the mixed model used in the back-
cross was also used for the AIL analyses. In addition to
sex and experiment, population cluster (1–5) was fitted
as a fixed effect to account for population structure. A
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Bonferroni correction for multiple testing was applied.
After Bonferroni correction significance thresholds were
P ≤ 1.75 × 10−7 and P ≤ 3.50 × 10−6 for genome-wide (P ≤
0.05) and suggestive levels, corresponding to -log10(P) of
6.75 and 5.45, respectively. In addition, a search for
SNPs significant at the chromosome-wide level was
performed.
SNP validation
Individual SNP markers that were significant at the gen-
ome- and chromosome-wide level in GWAS were fur-
ther verified in an association analysis as described for
the back-cross. This model also yielded estimates of the
magnitude of the significant SNPs effects as described
previously by [76].
Finally, the extent of LD among the significant SNP
markers was calculated and LD blocks were built as de-
scribed for the back-cross.
Further analyses pertaining to both experiments
Annotation of the genes in the QTL candidate regions
The Biomart data mining tool within the Ensembl data-
base (http://www.ensembl.org/biomart/martview/) and
the Gal-gal4 assembly were used to locate genes in the
candidate regions for Campylobacter colonisation resist-
ance identified by the QTL mapping analysis and GWAS
for the back-cross and AIL populations. In the case of
GWAS, the limits of genomic candidate regions were
determined by the LD block structure and the LD
present among the significant SNP markers and the
neighbouring markers.
The Variant Effect Predictor tool within the Ensembl
database (http://www.ensembl.org/Tools/VEP) and the
Gal-gal4 assembly were used to determine the location
of the significant SNPs identified in the GWAS analyses
on the reference genome. The effect of SNPs located in
exonic regions on the protein sequence was determined
with a SIFT prediction [77] of the protein sequence
changes.
Re-sequencing data analysis
The two parental lines (61 and N) were fully re-
sequenced to 15–20 fold coverage, using pools of 10 in-
dividuals per line. Sequencing was performed on Illu-
mina GAIIx platform using a paired end protocol [74].
Re-sequencing data of the candidate regions for Cam-
pylobacter colonisation resistance, derived from both the
back-cross and AIL analysis results, was extracted. More
specifically, the extracted sequence included the gene in
question and 1 kb upstream and 1 kb downstream of the
gene. The SNVs between the two parental lines and the
reference genome in these regions were detected using
the Mpileup tool for SNP calling (SAMtools v0.1.7). De-
tected SNVs were annotated using the VEP tool within
the Ensembl database (http://www.ensembl.org/Tools/
VEP). Information for all SNVs present in the regions of
interest was collated. SNV that were in common in the
two parental lines but different from the reference gen-
ome were filtered out. We separated SNVs into categor-
ies based on their relationship to genes. These categories
were exonic, intronic, and 1000 bp upstream and down-
stream. Within the exonic category, there were add-
itional subcategories of UTR and CDS. For SNV’s
occurring in CDS regions we also predicted SNV effect
as being synonymous, missense, nonsense (stop gain), or
splicing. SIFT predictions of the effects of CDS SNVs
(tolerated or deleterious) were also acquired through
VEP. While mutations in transcribed regions can lead to
altered transcriptional products, mutations in regulatory
regions can affect transcription rates which ultimately al-
ters phenotype. However, due to the lack of regulatory
element annotation in chickens, we developed our own
pipeline for predicting TATA boxes and CpG islands.
Tata boxes are short DNA regions which act as Tran-
scription Factor Binding sites. CGIs are interspersed
DNA sequences that deviate significantly from the aver-
age genomic pattern by being GC-rich, and predomin-
antly non-methylated. TATA boxes were predicted by
looking for TATA box motifs identified in humans
(Computational modeling of oligonucleotide positional
densities for human promoter prediction) within the
region 20–40 bp upstream of each gene. CpG islands
were predicted by using 100 bp windows and scanning
across the 1000 bp upstream region with 1 bp intervals
to find >200 bp regions with >50 % GC content and an
Observed/Expected ratio greater than 0.6 (CpG Islands
in Vertebrate Genomes, http://www.bioinformatics.org/
sms2/cpg_islands.html). By intersecting our SNV data
with our predicted TATA boxes and CpG islands we were
able to analyse putative regulatory region mutations.
All the genes, including micro RNAs, were ranked on
the rate of non-synonymous coding SNV (dN/L), rate of
non-synonymous to synonymous SNV (dN/dS), rate of
exonic SNV, rate of intronic SNV.
Pathway analysis
The gene lists in the QTL candidate regions for Campylo-
bacter colonisation resistance were analysed using the IPA
programme (www.ingenuity.com) in order to identify
canonical pathways and gene networks constructed by the
products of the genes located there. IPA constructs many
possible upstream regulators, pathways and networks
serving as hypotheses for the biological mechanism
underlying the data based on a large-scale causal network
derived from the Ingenuity Knowledge Base. Then, IPA
infers the most suitable pathways and networks based on
their statistical significance, thus a threshold above which
the pathways are significant is derived.
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Gene expression analysis
Genes whose expression was studied included CXCLi1
and CXCLi2. Total RNA from a caecal tonsil was iso-
lated from four replicate control birds and eight repli-
cate infected birds per line (61 and N) using the RNeasy
Mini Kit (Qiagen West Sussex, United Kingdom) follow-
ing the manufacturer’s instructions. For each gene,
mRNA levels were quantified using TaqMan quantitative
RT-PCR. Primers and probes for the 28S rRNA, CXCLi1
and CXCLi2 genes were as described previously [78, 79].
TaqMan assays were performed as described by Sutton
et al. [80]. Data was expressed as cycle threshold (Ct)
value, which was normalised using the formula; Ct + (N′
t-C′t)*(S/S′) where N′t is the mean Ct value for 28S
RNA among all samples, C′t is the mean value for 28S
RNA in the sample and the S and S′ are the slopes of re-
gression of the standard plots for the specific cytokine
or chemokine mRNA and the 28S RNA, respectively.
Expression data was calculated as fold changes com-
pared with the mean of the control mock-infected sam-
ples. Results are expressed as the mean of the fold
changes between replicate samples and error bars repre-
sent the standard error of this mean. Differences
between control and infected samples were examined
with an analysis of variance.
Ethics
All animal experiments were conducted in accordance
with the Animals (Scientific Procedures) Act 1986, with
the approval of the Ethical Review Committee of The
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and the Animal Welfare and Ethical Review Body of The
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Availability of supporting data
The SNP data used in this study is available in NCBI
dbSNP at the following web page: http://www.ncbi.nlm.
nih.gov/SNP/snp_viewBatch.cgi?sbid=1062063. The same
data is also available at the National Avian Research
Facility website through the link: http://www.narf.ac.uk/
VariationDatabase.
Additional files
Additional file 1: Table S1 Levels of C. jejuni colonisation in the
caeca of line 61, line N, back-cross and advanced intercross line birds.
The measurements took place one, two, three, four and five days
after challenge at 3 weeks of age. Data are presented as mean log10
(CFU/g) ± standard deviation of the mean. (XLSX 12 kb)
Additional file 2: Figure S1 Manhattan plot and Q-Q plot displaying
the GWAS results from the back-cross experiment. Genomic location is
plotted against -log10(P) in the Manhattan plot (above). Suggestive
genome-wide threshold is shown as a horizontal line. Q–Q plot (below)
of observed P-values against the expected P-values for Campylobacter gut
colonisation (log-transformed number of C. jejuni per gram of caecal
contents). (PPTX 1422 kb)
Additional file 3: Figure S2 Manhattan plot and Q-Q plot displaying
the GWAS results from the AIL experiment (binary (0/1) phenotypes).
Genomic location is plotted against -log10(P). Genome-wide (P < 0.05)
and suggestive genome-wide thresholds are shown as dashed lines. Q–Q
plot (below) of observed P-values against the expected P-values for
Campylobacter gut colonisation level. (PPTX 1524 kb)
Additional file 4: Table S2 Genes located in the QTL candidate regions
for Campylobacter colonisation resistance. (XLSX 27 kb)
Additional file 5: Figure S3 Linkage disequilibrium (LD) pattern for
significant SNPs on chromosome 14. LD between SNPs in the 0.4 Mb on
chromosome 14 region. LD blocks are marked with triangles. The
significant markers are illustrated with a blue arrow. Strongest LD signals
are in red and weakest in white. (PPTX 2065 kb)
Additional file 6: Figure S4 Linkage disequilibrium (LD) pattern for
significant SNPs on chromosome 4. LD between SNPs in the 0.4 Mb on
chromosome 4 region. LD blocks are marked with triangles. The
significant marker is illustrated with a blue arrow. Strongest LD signals are
in red and weakest in white. (PPTX 1646 kb)
Additional file 7: Figure S5 Linkage disequilibrium (LD) block containing
the significant SNP identified on chromosome 16. (PPTX 1681 kb)
Additional file 8: Figure S6 Summary statistics of the single nucleotide
variants identified in the candidate regions for Campylobacter
colonisation resistance. (PNG 41 kb)
Additional file 9: Table S3 List of single nucleotide variants located in
the candidate regions for Campylobacter colonisation resistance. Variant
Effect Predictor annotation results, SIFT predictions and allelic frequencies
per each parental line are also presented. (XLSX 1242 kb)
Additional file 10: Table S4 Genes located in the QTL candidate
regions for Campylobacter resistance containing splicing, 5′UTR, both
missense and UTR, CpG sites SNVs. (XLSX 14 kb)
Additional file 11: Figure S7 Network analysis using IPA software. The
two networks (A related to immunological disease and hereditary
disorder) and (B related to cell cycle, cell death and survival, connective
tissue development and function) illustrate molecular interactions
between products of candidate genes selected from QTL regions from
the AIL. Arrows with solid lines represent direct interactions, and arrows
with broken lines represent indirect interactions. The white colour
indicates gene products added to the IPA analysis because of their
interaction with the target gene products. (PPTX 1586 kb)
Additional file 12: Figure S8 Chemokine gene expression. Quantitation
of CXCLi1 and CXCLi2 mRNA expression in caecal tonsils of line 61 and
line N Campylobacter jejuni infected birds at 5 days post infection. Data
are expressed as the fold change in mRNA levels when samples from
infected birds were compared to non-infected birds of the same age
from each line. Error bars show ± S.E.M. Asterisks indicate significant
differences (P < 0.05) between line 61 and line N. (PPTX 204 kb)
Additional file 13: Table S5 List of selected candidate genes for
Campylobacter colonisation resistance detected with the back-cross and
AIL experiment. Expression of the candidate genes for Campylobacter
resistance identified in the present study using data from previously
published studies of other poultry infections. (XLSX 15 kb)
Additional file 14: Table S6 List of SNP markers used in the back-cross
analysis. (XLSX 48 kb)
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